These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 23980264)

  • 1. Three MRSA vaccines in early clincial trials.
    Riedmann EM
    Hum Vaccin Immunother; 2012 Dec; 8(12):1742. PubMed ID: 23980264
    [No Abstract]   [Full Text] [Related]  

  • 2. Will we ever see the approval of a Staphylococcus aureus vaccine?
    Patti JM
    Expert Rev Anti Infect Ther; 2011 Oct; 9(10):845-6. PubMed ID: 21973294
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapeutic strategies to combat staphylococcal infections.
    Ohlsen K; Lorenz U
    Int J Med Microbiol; 2010 Aug; 300(6):402-10. PubMed ID: 20547101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus vaccine for orthopedic patients: an economic model and analysis.
    Lee BY; Wiringa AE; Bailey RR; Lewis GJ; Feura J; Muder RR
    Vaccine; 2010 Mar; 28(12):2465-71. PubMed ID: 20064479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges for a universal Staphylococcus aureus vaccine.
    Proctor RA
    Clin Infect Dis; 2012 Apr; 54(8):1179-86. PubMed ID: 22354924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine against toxic shock syndrome in a first-in-man clinical trial.
    Roetzer A; Jilma B; Eibl MM
    Expert Rev Vaccines; 2017 Feb; 16(2):81-83. PubMed ID: 27918218
    [No Abstract]   [Full Text] [Related]  

  • 7. Expectations regarding vaccines and immune therapies directed against Staphylococcus aureus alpha-hemolysin.
    Kernodle DS
    J Infect Dis; 2011 Jun; 203(11):1692-3; author reply 1693-4. PubMed ID: 21593000
    [No Abstract]   [Full Text] [Related]  

  • 8. Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials.
    Bagnoli F; Bertholet S; Grandi G
    Front Cell Infect Microbiol; 2012; 2():16. PubMed ID: 22919608
    [No Abstract]   [Full Text] [Related]  

  • 9. A comprehensive synthetic library of poly-N-acetyl glucosamines enabled vaccine against lethal challenges of Staphylococcus aureus.
    Tan Z; Yang W; O'Brien NA; Pan X; Ramadan S; Marsh T; Hammer N; Cywes-Bentley C; Vinacur M; Pier GB; Gildersleeve JC; Huang X
    Nat Commun; 2024 Apr; 15(1):3420. PubMed ID: 38658531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methicillin-resistant Staphylococcus aureus: an update.
    Durai R; Ng PC; Hoque H
    AORN J; 2010 May; 91(5):599-606; quiz 607-9. PubMed ID: 20451002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The World Needs a Staph Vaccine-New Research Could Bring It a Step Closer.
    Coffey D
    JAMA; 2024 Aug; 332(8):607-609. PubMed ID: 39093572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal vaccine development: review of past failures and plea for a future evaluation of vaccine efficacy not only on staphylococcal infections but also on mucosal carriage.
    Botelho-Nevers E; Verhoeven P; Paul S; Grattard F; Pozzetto B; Berthelot P; Lucht F
    Expert Rev Vaccines; 2013 Nov; 12(11):1249-59. PubMed ID: 24111513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus.
    John CC; Schreiber JR
    Pediatr Clin North Am; 2006 Aug; 53(4):699-713. PubMed ID: 16873000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Sugar Cloak of Invisibility.
    Waldman AJ; Bertozzi CR
    Biochemistry; 2019 May; 58(19):2385-2386. PubMed ID: 31041861
    [No Abstract]   [Full Text] [Related]  

  • 15. Release of Staphylococcus aureus extracellular vesicles and their application as a vaccine platform.
    Wang X; Thompson CD; Weidenmaier C; Lee JC
    Nat Commun; 2018 Apr; 9(1):1379. PubMed ID: 29643357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the potential public health impact of a Staphylococcus aureus vaccine through use of population-based surveillance for invasive methicillin-resistant S. aureus disease in the United States.
    Lucero CA; Hageman J; Zell ER; Bulens S; Nadle J; Petit S; Gershman K; Ray S; Harrison LH; Lynfield R; Dumyati G; Townes JM; Schaffner W; Fridkin SK;
    Vaccine; 2009 Aug; 27(37):5061-8. PubMed ID: 19576943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lethal CD4 T Cell Responses Induced by Vaccination Against Staphylococcus aureus Bacteremia.
    Karauzum H; Haudenschild CC; Moore IN; Mahmoudieh M; Barber DL; Datta SK
    J Infect Dis; 2017 Apr; 215(8):1231-1239. PubMed ID: 28329242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospects for active and passive immunization against Staphylococcus aureus.
    Shinefield HR; Black S
    Pediatr Infect Dis J; 2006 Feb; 25(2):167-8. PubMed ID: 16462297
    [No Abstract]   [Full Text] [Related]  

  • 19. Prospects for a MRSA vaccine.
    Lindsay JA
    Future Microbiol; 2007 Feb; 2(1):1-3. PubMed ID: 17661669
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing postoperative Staphylococcus aureus infections: the search continues.
    Malani PN
    JAMA; 2013 Apr; 309(13):1408-9. PubMed ID: 23549587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.